Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Alveoli | 26 | 2016 | 71 | 5.120 |
Why?
|
Lung | 31 | 2021 | 1261 | 5.110 |
Why?
|
Particulate Matter | 15 | 2020 | 102 | 5.010 |
Why?
|
Macrophages, Alveolar | 10 | 2021 | 57 | 4.880 |
Why?
|
Fibroblasts | 13 | 2021 | 755 | 3.870 |
Why?
|
Acute Lung Injury | 9 | 2019 | 64 | 3.520 |
Why?
|
Air Pollutants | 8 | 2020 | 92 | 3.140 |
Why?
|
Mitochondria | 12 | 2020 | 553 | 2.800 |
Why?
|
Air Pollution | 8 | 2020 | 92 | 2.790 |
Why?
|
Transforming Growth Factor beta | 11 | 2020 | 321 | 2.750 |
Why?
|
Pulmonary Fibrosis | 9 | 2019 | 137 | 2.490 |
Why?
|
Lung Diseases | 7 | 2018 | 269 | 2.250 |
Why?
|
Pulmonary Edema | 9 | 2019 | 50 | 2.210 |
Why?
|
Collagen | 7 | 2021 | 293 | 2.200 |
Why?
|
Idiopathic Pulmonary Fibrosis | 6 | 2019 | 196 | 2.050 |
Why?
|
Orthomyxoviridae Infections | 5 | 2018 | 46 | 2.050 |
Why?
|
Myofibroblasts | 4 | 2021 | 47 | 1.940 |
Why?
|
Mice, Inbred C57BL | 31 | 2020 | 3213 | 1.920 |
Why?
|
Reactive Oxygen Species | 18 | 2020 | 490 | 1.900 |
Why?
|
Animals | 77 | 2021 | 27360 | 1.900 |
Why?
|
Cells, Cultured | 20 | 2021 | 2880 | 1.850 |
Why?
|
Mice | 47 | 2021 | 11757 | 1.770 |
Why?
|
Fibrosis | 5 | 2021 | 234 | 1.680 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 10 | 2016 | 79 | 1.680 |
Why?
|
Respiratory Mucosa | 5 | 2021 | 88 | 1.680 |
Why?
|
Inflammation | 10 | 2020 | 972 | 1.630 |
Why?
|
Endothelium, Vascular | 6 | 2021 | 433 | 1.600 |
Why?
|
Glycolysis | 7 | 2021 | 135 | 1.500 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 4 | 2014 | 23 | 1.470 |
Why?
|
Epithelial Cells | 11 | 2019 | 689 | 1.470 |
Why?
|
Cell Differentiation | 7 | 2021 | 1522 | 1.420 |
Why?
|
Interleukin-6 | 8 | 2018 | 261 | 1.380 |
Why?
|
Endothelial Cells | 6 | 2021 | 459 | 1.370 |
Why?
|
Humans | 109 | 2021 | 89287 | 1.360 |
Why?
|
Albuterol | 4 | 2014 | 35 | 1.340 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2021 | 100 | 1.290 |
Why?
|
Receptors, Adrenergic, beta-2 | 7 | 2007 | 36 | 1.290 |
Why?
|
Hypoxia | 7 | 2017 | 651 | 1.280 |
Why?
|
Influenza A Virus, H1N1 Subtype | 3 | 2014 | 104 | 1.280 |
Why?
|
Bleomycin | 9 | 2019 | 102 | 1.280 |
Why?
|
Lung Injury | 7 | 2014 | 53 | 1.240 |
Why?
|
Thrombosis | 3 | 2018 | 302 | 1.210 |
Why?
|
Phosphoglycerate Dehydrogenase | 2 | 2018 | 7 | 1.190 |
Why?
|
Sodium | 7 | 2012 | 331 | 1.160 |
Why?
|
Alveolar Epithelial Cells | 3 | 2019 | 18 | 1.140 |
Why?
|
Male | 59 | 2021 | 42372 | 1.110 |
Why?
|
Influenza A virus | 3 | 2018 | 169 | 1.110 |
Why?
|
Disease Models, Animal | 16 | 2019 | 2364 | 1.100 |
Why?
|
Leptin | 3 | 2014 | 102 | 1.100 |
Why?
|
Signal Transduction | 16 | 2020 | 3379 | 1.100 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2017 | 155 | 1.080 |
Why?
|
Bronchoalveolar Lavage | 3 | 2015 | 26 | 1.050 |
Why?
|
Transforming Growth Factor beta1 | 6 | 2019 | 89 | 1.040 |
Why?
|
Mice, Knockout | 16 | 2020 | 1998 | 1.030 |
Why?
|
Oxygen | 6 | 2020 | 742 | 1.000 |
Why?
|
AMP-Activated Protein Kinases | 3 | 2011 | 64 | 1.000 |
Why?
|
Gene Transfer Techniques | 6 | 2007 | 153 | 0.970 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 5 | 2019 | 258 | 0.960 |
Why?
|
Iron | 2 | 2015 | 168 | 0.910 |
Why?
|
Glutamine | 3 | 2019 | 80 | 0.900 |
Why?
|
Asthma | 6 | 2015 | 978 | 0.890 |
Why?
|
Bronchoalveolar Lavage Fluid | 11 | 2014 | 126 | 0.880 |
Why?
|
Scleroderma, Systemic | 3 | 2012 | 53 | 0.870 |
Why?
|
Serine | 3 | 2020 | 104 | 0.870 |
Why?
|
Aging | 2 | 2021 | 717 | 0.860 |
Why?
|
Rats | 20 | 2017 | 4041 | 0.860 |
Why?
|
Toll-Like Receptor 4 | 2 | 2014 | 91 | 0.850 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2014 | 43 | 0.840 |
Why?
|
Macrophage Activation | 2 | 2020 | 49 | 0.820 |
Why?
|
Electron Transport Complex I | 2 | 2020 | 30 | 0.810 |
Why?
|
Perioperative Care | 2 | 2014 | 170 | 0.810 |
Why?
|
Oxidative Stress | 3 | 2014 | 458 | 0.810 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2020 | 43 | 0.810 |
Why?
|
Sleep Apnea, Obstructive | 3 | 2017 | 216 | 0.800 |
Why?
|
Geotrichosis | 1 | 2021 | 1 | 0.790 |
Why?
|
Energy Metabolism | 2 | 2021 | 277 | 0.790 |
Why?
|
Glucose Transporter Type 3 | 1 | 2021 | 2 | 0.780 |
Why?
|
Pneumonia | 5 | 2012 | 182 | 0.780 |
Why?
|
Respiration, Artificial | 6 | 2010 | 352 | 0.770 |
Why?
|
Rats, Sprague-Dawley | 14 | 2017 | 1237 | 0.770 |
Why?
|
Hyperoxia | 5 | 2012 | 35 | 0.760 |
Why?
|
Cellular Microenvironment | 1 | 2021 | 29 | 0.750 |
Why?
|
Hypercapnia | 4 | 2010 | 44 | 0.750 |
Why?
|
Hydrogen Peroxide | 2 | 2020 | 159 | 0.750 |
Why?
|
Activating Transcription Factor 4 | 1 | 2020 | 15 | 0.740 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 29 | 0.740 |
Why?
|
beta Catenin | 3 | 2014 | 266 | 0.730 |
Why?
|
Apoptosis | 6 | 2013 | 1717 | 0.720 |
Why?
|
Molecular Imaging | 1 | 2021 | 65 | 0.720 |
Why?
|
Succinates | 1 | 2020 | 21 | 0.720 |
Why?
|
Occupational Diseases | 2 | 2011 | 55 | 0.710 |
Why?
|
Amino Acids | 1 | 2021 | 245 | 0.710 |
Why?
|
Carboxy-Lyases | 1 | 2020 | 22 | 0.710 |
Why?
|
Mycoses | 1 | 2020 | 46 | 0.710 |
Why?
|
Inhalation Exposure | 2 | 2018 | 31 | 0.710 |
Why?
|
Heart Arrest | 2 | 2020 | 279 | 0.710 |
Why?
|
Critical Illness | 5 | 2013 | 306 | 0.700 |
Why?
|
Myocardial Stunning | 1 | 2020 | 12 | 0.700 |
Why?
|
Gene Expression Regulation | 8 | 2017 | 1975 | 0.700 |
Why?
|
Glutaminase | 1 | 2019 | 12 | 0.690 |
Why?
|
Superoxides | 1 | 2020 | 74 | 0.690 |
Why?
|
Critical Care Nursing | 1 | 2019 | 4 | 0.680 |
Why?
|
Pseudomonas Infections | 2 | 2013 | 99 | 0.680 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 147 | 0.670 |
Why?
|
Biocompatible Materials | 2 | 2011 | 198 | 0.670 |
Why?
|
Metformin | 2 | 2018 | 124 | 0.670 |
Why?
|
Capillary Permeability | 2 | 2017 | 130 | 0.660 |
Why?
|
Blood Coagulation | 2 | 2011 | 92 | 0.660 |
Why?
|
Female | 34 | 2021 | 46156 | 0.650 |
Why?
|
DNA, Mitochondrial | 2 | 2016 | 187 | 0.640 |
Why?
|
Cell Line | 10 | 2018 | 2496 | 0.640 |
Why?
|
Bacterial Infections | 1 | 2020 | 184 | 0.640 |
Why?
|
Behavior Therapy | 1 | 2019 | 87 | 0.630 |
Why?
|
DNA Glycosylases | 2 | 2016 | 25 | 0.630 |
Why?
|
Airway Remodeling | 1 | 2018 | 9 | 0.620 |
Why?
|
Glucose | 1 | 2021 | 630 | 0.620 |
Why?
|
Lipopolysaccharides | 5 | 2020 | 293 | 0.610 |
Why?
|
Endothelin-1 | 1 | 2017 | 40 | 0.590 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 232 | 0.590 |
Why?
|
DNA Damage | 2 | 2016 | 371 | 0.590 |
Why?
|
Phosphofructokinase-2 | 1 | 2017 | 2 | 0.570 |
Why?
|
Monocytes | 2 | 2017 | 218 | 0.570 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2016 | 4 | 0.570 |
Why?
|
Intra-Abdominal Fat | 1 | 2017 | 32 | 0.570 |
Why?
|
Mediastinal Cyst | 1 | 2016 | 3 | 0.570 |
Why?
|
Burns | 1 | 2019 | 141 | 0.560 |
Why?
|
Regional Blood Flow | 1 | 2017 | 198 | 0.560 |
Why?
|
Oxidants | 3 | 2013 | 86 | 0.560 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2016 | 45 | 0.560 |
Why?
|
Stem Cells | 1 | 2019 | 372 | 0.560 |
Why?
|
Sirtuin 3 | 1 | 2016 | 30 | 0.550 |
Why?
|
GTP Phosphohydrolases | 1 | 2017 | 74 | 0.550 |
Why?
|
Pleura | 1 | 2016 | 31 | 0.550 |
Why?
|
Respiratory Insufficiency | 4 | 2010 | 162 | 0.550 |
Why?
|
Cardiac Glycosides | 1 | 2016 | 5 | 0.540 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 25 | 0.540 |
Why?
|
Digoxin | 1 | 2016 | 21 | 0.540 |
Why?
|
Ouabain | 1 | 2016 | 24 | 0.530 |
Why?
|
Adenoviridae | 7 | 2011 | 349 | 0.530 |
Why?
|
Paracrine Communication | 1 | 2016 | 32 | 0.530 |
Why?
|
Keratinocytes | 1 | 2017 | 146 | 0.530 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2015 | 5 | 0.530 |
Why?
|
Down-Regulation | 3 | 2016 | 519 | 0.530 |
Why?
|
Electron Transport Complex III | 4 | 2012 | 13 | 0.530 |
Why?
|
Wood | 1 | 2015 | 19 | 0.520 |
Why?
|
Smoke | 1 | 2015 | 27 | 0.520 |
Why?
|
Transglutaminases | 1 | 2015 | 40 | 0.510 |
Why?
|
Pneumothorax | 1 | 2015 | 53 | 0.510 |
Why?
|
Influenza, Human | 2 | 2018 | 337 | 0.500 |
Why?
|
Asbestos, Crocidolite | 1 | 2015 | 2 | 0.500 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 645 | 0.490 |
Why?
|
Receptor, Adenosine A1 | 2 | 2012 | 8 | 0.490 |
Why?
|
Interferon Type I | 1 | 2016 | 185 | 0.490 |
Why?
|
GTP-Binding Proteins | 1 | 2015 | 145 | 0.490 |
Why?
|
Flow Cytometry | 2 | 2013 | 691 | 0.490 |
Why?
|
Emphysema | 1 | 2015 | 23 | 0.490 |
Why?
|
Antigens, Ly | 1 | 2014 | 37 | 0.490 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2014 | 4 | 0.480 |
Why?
|
Arthritis, Experimental | 1 | 2014 | 26 | 0.480 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2020 | 968 | 0.480 |
Why?
|
Adrenergic beta-Agonists | 3 | 2007 | 72 | 0.480 |
Why?
|
Hemorrhagic Disorders | 1 | 2014 | 2 | 0.480 |
Why?
|
Serpin E2 | 1 | 2014 | 4 | 0.470 |
Why?
|
Proteasome Inhibitors | 2 | 2011 | 52 | 0.470 |
Why?
|
Boronic Acids | 2 | 2011 | 56 | 0.470 |
Why?
|
Transcriptome | 1 | 2019 | 628 | 0.470 |
Why?
|
Babesiosis | 1 | 2014 | 4 | 0.470 |
Why?
|
Glucuronidase | 1 | 2014 | 23 | 0.470 |
Why?
|
Membrane Proteins | 3 | 2017 | 1223 | 0.470 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 352 | 0.470 |
Why?
|
Ion Transport | 5 | 2012 | 81 | 0.470 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2014 | 72 | 0.470 |
Why?
|
Gastrointestinal Tract | 2 | 2018 | 191 | 0.470 |
Why?
|
Th17 Cells | 1 | 2014 | 85 | 0.460 |
Why?
|
Bronchoscopy | 1 | 2015 | 160 | 0.460 |
Why?
|
PPAR gamma | 2 | 2011 | 73 | 0.460 |
Why?
|
Pyrazines | 2 | 2011 | 94 | 0.460 |
Why?
|
Antiviral Agents | 2 | 2020 | 478 | 0.450 |
Why?
|
Th2 Cells | 1 | 2014 | 147 | 0.450 |
Why?
|
Critical Care | 4 | 2021 | 382 | 0.450 |
Why?
|
Postoperative Complications | 2 | 2014 | 2283 | 0.450 |
Why?
|
Nitric Oxide | 1 | 2015 | 279 | 0.450 |
Why?
|
Particle Size | 5 | 2011 | 124 | 0.440 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2013 | 4 | 0.440 |
Why?
|
Antibodies, Neutralizing | 1 | 2014 | 120 | 0.440 |
Why?
|
Silicon Dioxide | 1 | 2013 | 40 | 0.440 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2014 | 135 | 0.440 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2013 | 5 | 0.440 |
Why?
|
Pneumonia, Viral | 2 | 2018 | 319 | 0.440 |
Why?
|
Pulmonary Embolism | 2 | 2006 | 228 | 0.440 |
Why?
|
Trachea | 2 | 2014 | 291 | 0.440 |
Why?
|
Receptors, Adrenergic, beta | 3 | 2014 | 73 | 0.420 |
Why?
|
5-Hydroxytryptophan | 1 | 2012 | 5 | 0.420 |
Why?
|
Environmental Exposure | 2 | 2018 | 322 | 0.420 |
Why?
|
Blotting, Western | 5 | 2017 | 794 | 0.420 |
Why?
|
Muscle Hypotonia | 2 | 2010 | 48 | 0.410 |
Why?
|
Antibodies, Viral | 1 | 2014 | 309 | 0.410 |
Why?
|
Bronchi | 1 | 2013 | 229 | 0.410 |
Why?
|
Antioxidants | 3 | 2009 | 226 | 0.410 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2010 | 59 | 0.410 |
Why?
|
Fluorobenzenes | 1 | 2012 | 33 | 0.400 |
Why?
|
Cytokines | 7 | 2018 | 802 | 0.400 |
Why?
|
Cell Membrane Permeability | 2 | 2014 | 120 | 0.400 |
Why?
|
Biomarkers | 5 | 2021 | 1765 | 0.400 |
Why?
|
Gastrointestinal Diseases | 3 | 2003 | 151 | 0.400 |
Why?
|
Graphite | 1 | 2011 | 12 | 0.400 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2012 | 82 | 0.390 |
Why?
|
Middle Aged | 16 | 2020 | 25945 | 0.390 |
Why?
|
Poloxamer | 1 | 2011 | 29 | 0.390 |
Why?
|
Salicylates | 2 | 2009 | 25 | 0.390 |
Why?
|
Mice, Transgenic | 5 | 2021 | 1574 | 0.390 |
Why?
|
Cell Movement | 5 | 2021 | 784 | 0.390 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 202 | 0.380 |
Why?
|
Gene Expression | 4 | 2016 | 1310 | 0.380 |
Why?
|
Gastrointestinal Microbiome | 1 | 2018 | 506 | 0.380 |
Why?
|
Oxygen Consumption | 2 | 2020 | 244 | 0.370 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2007 | 56 | 0.370 |
Why?
|
Reflex, Abnormal | 1 | 2010 | 6 | 0.370 |
Why?
|
Hypersensitivity | 1 | 2012 | 158 | 0.370 |
Why?
|
Organometallic Compounds | 2 | 2009 | 134 | 0.370 |
Why?
|
Spinocerebellar Degenerations | 1 | 2010 | 18 | 0.360 |
Why?
|
Tracheitis | 1 | 2010 | 3 | 0.360 |
Why?
|
Sleep Apnea, Central | 1 | 2010 | 14 | 0.360 |
Why?
|
Nanotubes | 1 | 2010 | 9 | 0.360 |
Why?
|
Coma | 1 | 2010 | 47 | 0.360 |
Why?
|
Cardiovascular Diseases | 3 | 2011 | 711 | 0.360 |
Why?
|
Mediastinal Emphysema | 1 | 2010 | 6 | 0.350 |
Why?
|
Helium | 1 | 2010 | 10 | 0.350 |
Why?
|
Calcium Channels | 1 | 2011 | 182 | 0.350 |
Why?
|
TCF Transcription Factors | 1 | 2009 | 24 | 0.350 |
Why?
|
Enzyme Activation | 4 | 2016 | 698 | 0.350 |
Why?
|
Dendritic Cells | 1 | 2013 | 449 | 0.350 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 2 | 2007 | 13 | 0.340 |
Why?
|
Protease Inhibitors | 1 | 2010 | 73 | 0.340 |
Why?
|
Oxidative Phosphorylation | 3 | 2020 | 54 | 0.340 |
Why?
|
Sulfonamides | 1 | 2012 | 318 | 0.340 |
Why?
|
Brain Stem | 1 | 2010 | 167 | 0.340 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2010 | 106 | 0.340 |
Why?
|
Epithelium | 5 | 2016 | 325 | 0.340 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2009 | 10 | 0.340 |
Why?
|
Ethanol | 1 | 2012 | 250 | 0.330 |
Why?
|
Adult | 16 | 2021 | 26578 | 0.330 |
Why?
|
Pyrimidines | 1 | 2012 | 373 | 0.330 |
Why?
|
Ubiquitin | 1 | 2010 | 96 | 0.330 |
Why?
|
Glycine | 2 | 2020 | 94 | 0.330 |
Why?
|
Hypnotics and Sedatives | 1 | 2010 | 131 | 0.330 |
Why?
|
Intellectual Disability | 1 | 2010 | 189 | 0.330 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2008 | 3 | 0.330 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2010 | 164 | 0.330 |
Why?
|
Developmental Disabilities | 1 | 2010 | 202 | 0.320 |
Why?
|
Dystroglycans | 1 | 2008 | 15 | 0.320 |
Why?
|
Adenosine | 2 | 2012 | 237 | 0.310 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 114 | 0.310 |
Why?
|
Nuclear Proteins | 1 | 2013 | 726 | 0.310 |
Why?
|
Pyridines | 1 | 2010 | 315 | 0.310 |
Why?
|
Cell Proliferation | 4 | 2018 | 1651 | 0.310 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 377 | 0.310 |
Why?
|
Carotid Artery Thrombosis | 1 | 2007 | 5 | 0.300 |
Why?
|
Neoplasms | 2 | 2021 | 3038 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 196 | 0.300 |
Why?
|
Electrochemotherapy | 1 | 2007 | 4 | 0.300 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 447 | 0.290 |
Why?
|
Aged | 11 | 2020 | 19142 | 0.290 |
Why?
|
Macrophages | 3 | 2017 | 571 | 0.290 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2021 | 31 | 0.290 |
Why?
|
Positive-Pressure Respiration | 3 | 2011 | 41 | 0.290 |
Why?
|
Sclerosing Solutions | 1 | 2006 | 5 | 0.290 |
Why?
|
Talc | 1 | 2006 | 4 | 0.290 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 699 | 0.280 |
Why?
|
Pleurodesis | 1 | 2006 | 8 | 0.280 |
Why?
|
Pulmonary Surfactants | 3 | 2004 | 19 | 0.280 |
Why?
|
Genetic Vectors | 4 | 2002 | 446 | 0.280 |
Why?
|
Hospital Mortality | 1 | 2009 | 387 | 0.280 |
Why?
|
Models, Biological | 4 | 2021 | 1765 | 0.270 |
Why?
|
Mice, Mutant Strains | 3 | 2013 | 231 | 0.270 |
Why?
|
Dietary Proteins | 1 | 2006 | 30 | 0.270 |
Why?
|
Alanine Transaminase | 1 | 2006 | 72 | 0.270 |
Why?
|
Bone Cements | 1 | 2006 | 9 | 0.270 |
Why?
|
Aspartate Aminotransferases | 1 | 2006 | 75 | 0.270 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2006 | 51 | 0.270 |
Why?
|
Genes, p53 | 1 | 2006 | 109 | 0.270 |
Why?
|
Extravascular Lung Water | 1 | 2006 | 5 | 0.270 |
Why?
|
Polymethyl Methacrylate | 1 | 2006 | 13 | 0.270 |
Why?
|
Histoplasma | 1 | 2006 | 14 | 0.260 |
Why?
|
Splenic Diseases | 1 | 2006 | 15 | 0.260 |
Why?
|
Sarcoidosis | 1 | 2006 | 72 | 0.260 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2006 | 71 | 0.260 |
Why?
|
Serum Albumin | 1 | 2006 | 127 | 0.260 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2005 | 8 | 0.260 |
Why?
|
Histoplasmosis | 1 | 2006 | 26 | 0.260 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2017 | 73 | 0.260 |
Why?
|
Bacteremia | 1 | 2006 | 102 | 0.260 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2017 | 282 | 0.260 |
Why?
|
Confusion | 1 | 2005 | 7 | 0.250 |
Why?
|
Paralysis | 1 | 2005 | 22 | 0.250 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2013 | 1940 | 0.250 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2005 | 52 | 0.250 |
Why?
|
Leukemia, Lymphoid | 1 | 2005 | 72 | 0.250 |
Why?
|
Aged, 80 and over | 4 | 2020 | 6802 | 0.250 |
Why?
|
West Nile Fever | 1 | 2005 | 21 | 0.250 |
Why?
|
Adrenal Cortex Hormones | 1 | 2006 | 266 | 0.240 |
Why?
|
Receptors, Adrenergic, beta-1 | 3 | 2014 | 8 | 0.240 |
Why?
|
Osteoporosis | 1 | 2006 | 122 | 0.240 |
Why?
|
Interleukin-8 | 2 | 2015 | 86 | 0.240 |
Why?
|
Lypressin | 1 | 2004 | 1 | 0.240 |
Why?
|
Antibodies | 1 | 2006 | 353 | 0.240 |
Why?
|
Body Weight | 2 | 2017 | 452 | 0.240 |
Why?
|
Oximetry | 1 | 2005 | 82 | 0.240 |
Why?
|
Calcinosis | 1 | 2006 | 230 | 0.230 |
Why?
|
Vasopressins | 1 | 2004 | 50 | 0.230 |
Why?
|
Cell Death | 3 | 2011 | 262 | 0.230 |
Why?
|
Vasoconstrictor Agents | 1 | 2004 | 56 | 0.230 |
Why?
|
Cellular Senescence | 2 | 2015 | 103 | 0.230 |
Why?
|
Mice, Inbred BALB C | 3 | 2012 | 1088 | 0.230 |
Why?
|
Chemokines | 2 | 2015 | 74 | 0.230 |
Why?
|
RNA, Messenger | 5 | 2013 | 2014 | 0.220 |
Why?
|
Titrimetry | 1 | 2003 | 15 | 0.220 |
Why?
|
Laminin | 2 | 2015 | 89 | 0.220 |
Why?
|
Shock, Septic | 1 | 2004 | 105 | 0.220 |
Why?
|
Long-Term Care | 1 | 2003 | 61 | 0.210 |
Why?
|
Mice, Inbred C3H | 2 | 2014 | 371 | 0.210 |
Why?
|
Sodium Cyanide | 1 | 2002 | 6 | 0.210 |
Why?
|
Gastric Mucosa | 1 | 2003 | 67 | 0.210 |
Why?
|
Carcinoma | 1 | 2006 | 443 | 0.210 |
Why?
|
Fluorocarbon Polymers | 1 | 2002 | 3 | 0.210 |
Why?
|
Quadriplegia | 1 | 2002 | 23 | 0.210 |
Why?
|
Cell Count | 2 | 2017 | 200 | 0.210 |
Why?
|
Hypokalemia | 1 | 2002 | 23 | 0.210 |
Why?
|
Poisoning | 1 | 2002 | 42 | 0.210 |
Why?
|
Thoracic Surgery, Video-Assisted | 2 | 2016 | 30 | 0.210 |
Why?
|
Soccer | 1 | 2002 | 19 | 0.210 |
Why?
|
Phosphorylation | 2 | 2016 | 1130 | 0.210 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 2660 | 0.200 |
Why?
|
Stress, Physiological | 2 | 2020 | 232 | 0.200 |
Why?
|
Status Asthmaticus | 1 | 2002 | 9 | 0.200 |
Why?
|
Genetic Therapy | 1 | 2004 | 370 | 0.200 |
Why?
|
Anesthesia, Inhalation | 1 | 2002 | 36 | 0.200 |
Why?
|
Pleural Effusion | 2 | 2015 | 47 | 0.200 |
Why?
|
Geotrichum | 1 | 2021 | 1 | 0.200 |
Why?
|
Neutrophils | 3 | 2014 | 308 | 0.200 |
Why?
|
Emergencies | 1 | 2002 | 121 | 0.200 |
Why?
|
Breath Tests | 1 | 2001 | 57 | 0.200 |
Why?
|
Receptors, Leptin | 2 | 2014 | 32 | 0.190 |
Why?
|
Mechanical Phenomena | 1 | 2021 | 15 | 0.190 |
Why?
|
Autopsy | 1 | 2021 | 122 | 0.190 |
Why?
|
Tachycardia, Ventricular | 1 | 2002 | 124 | 0.190 |
Why?
|
Retrospective Studies | 6 | 2020 | 9047 | 0.190 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2021 | 85 | 0.180 |
Why?
|
Antifungal Agents | 1 | 2021 | 120 | 0.180 |
Why?
|
Bortezomib | 2 | 2011 | 82 | 0.180 |
Why?
|
Random Allocation | 2 | 2020 | 327 | 0.180 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 21 | 0.180 |
Why?
|
Immunocompromised Host | 1 | 2021 | 142 | 0.180 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 374 | 0.180 |
Why?
|
Laryngismus | 1 | 2000 | 3 | 0.180 |
Why?
|
Suicide | 1 | 2002 | 151 | 0.180 |
Why?
|
Salmeterol Xinafoate | 2 | 2014 | 16 | 0.180 |
Why?
|
Edetic Acid | 1 | 2000 | 42 | 0.180 |
Why?
|
Bronchoconstriction | 1 | 2000 | 56 | 0.170 |
Why?
|
Biological Transport, Active | 3 | 2005 | 102 | 0.170 |
Why?
|
Survival Analysis | 3 | 2012 | 1534 | 0.170 |
Why?
|
Cytoskeleton | 1 | 2021 | 195 | 0.170 |
Why?
|
Biological Products | 1 | 2002 | 155 | 0.170 |
Why?
|
Sodium Channels | 4 | 2005 | 130 | 0.170 |
Why?
|
Respiratory System | 1 | 2020 | 116 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2020 | 267 | 0.170 |
Why?
|
Intensive Care Units | 3 | 2021 | 396 | 0.170 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 887 | 0.170 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 187 | 0.170 |
Why?
|
Wasting Syndrome | 1 | 2018 | 3 | 0.160 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2018 | 4 | 0.160 |
Why?
|
Catecholamines | 2 | 2014 | 92 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2020 | 340 | 0.160 |
Why?
|
NF-kappa B | 2 | 2013 | 466 | 0.160 |
Why?
|
Myocardial Ischemia | 1 | 2000 | 162 | 0.160 |
Why?
|
Collagen Type I | 2 | 2016 | 72 | 0.160 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 2015 | 0.160 |
Why?
|
Electron Transport | 1 | 2018 | 74 | 0.160 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 742 | 0.160 |
Why?
|
Oncogene Proteins | 1 | 2019 | 61 | 0.160 |
Why?
|
Superoxide Dismutase | 2 | 2010 | 177 | 0.160 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 540 | 0.160 |
Why?
|
Cell Line, Tumor | 4 | 2014 | 2555 | 0.160 |
Why?
|
Skin | 2 | 2012 | 582 | 0.160 |
Why?
|
Spleen | 2 | 2012 | 433 | 0.160 |
Why?
|
Muscles | 1 | 2018 | 193 | 0.160 |
Why?
|
Fatty Acids | 1 | 2019 | 134 | 0.150 |
Why?
|
NIH 3T3 Cells | 1 | 2018 | 110 | 0.150 |
Why?
|
Muscle Proteins | 1 | 2018 | 133 | 0.150 |
Why?
|
Computational Biology | 1 | 2021 | 542 | 0.150 |
Why?
|
Phenotype | 2 | 2014 | 2440 | 0.150 |
Why?
|
Cell Respiration | 1 | 2017 | 19 | 0.150 |
Why?
|
Transgenes | 3 | 2002 | 185 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 1596 | 0.150 |
Why?
|
Risk Assessment | 3 | 2013 | 2302 | 0.150 |
Why?
|
Inpatients | 1 | 2020 | 310 | 0.140 |
Why?
|
Sepsis | 1 | 2021 | 320 | 0.140 |
Why?
|
Epigenomics | 1 | 2018 | 103 | 0.140 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2017 | 48 | 0.140 |
Why?
|
Cross-Over Studies | 1 | 2018 | 389 | 0.140 |
Why?
|
Air | 1 | 2017 | 62 | 0.140 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 312 | 0.140 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2020 | 223 | 0.140 |
Why?
|
Time Factors | 2 | 2017 | 5336 | 0.140 |
Why?
|
Deoxyguanosine | 1 | 2016 | 28 | 0.140 |
Why?
|
Cytoprotection | 1 | 2016 | 47 | 0.140 |
Why?
|
Neuropeptides | 1 | 2017 | 114 | 0.140 |
Why?
|
Epidermis | 1 | 2017 | 102 | 0.140 |
Why?
|
Heart Failure | 1 | 2006 | 1183 | 0.140 |
Why?
|
Survival Rate | 2 | 2012 | 1901 | 0.140 |
Why?
|
Organ Size | 1 | 2017 | 370 | 0.130 |
Why?
|
Humic Substances | 1 | 2015 | 1 | 0.130 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 511 | 0.130 |
Why?
|
Cyclooxygenase 2 | 1 | 2016 | 99 | 0.130 |
Why?
|
Metabolic Syndrome | 1 | 2017 | 123 | 0.130 |
Why?
|
Polysomnography | 2 | 2010 | 151 | 0.130 |
Why?
|
Back Pain | 1 | 2015 | 42 | 0.130 |
Why?
|
Swine | 1 | 2017 | 582 | 0.130 |
Why?
|
Cough | 1 | 2015 | 55 | 0.130 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 108 | 0.130 |
Why?
|
MAP Kinase Signaling System | 2 | 2013 | 198 | 0.130 |
Why?
|
Obesity | 2 | 2017 | 971 | 0.130 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2015 | 45 | 0.130 |
Why?
|
Phosphatidylcholines | 1 | 2015 | 49 | 0.120 |
Why?
|
Gene Knockdown Techniques | 2 | 2012 | 247 | 0.120 |
Why?
|
Madin Darby Canine Kidney Cells | 1 | 2014 | 19 | 0.120 |
Why?
|
Mice, Obese | 1 | 2014 | 44 | 0.120 |
Why?
|
Cyclic AMP | 2 | 2007 | 274 | 0.120 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2014 | 1 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2015 | 226 | 0.120 |
Why?
|
Eosinophils | 1 | 2015 | 194 | 0.120 |
Why?
|
Histocytochemistry | 1 | 2014 | 130 | 0.120 |
Why?
|
Insulin Resistance | 1 | 2017 | 353 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 260 | 0.120 |
Why?
|
Antithrombin III | 1 | 2014 | 9 | 0.120 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 337 | 0.120 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 285 | 0.120 |
Why?
|
Hepatocyte Growth Factor | 1 | 2014 | 85 | 0.120 |
Why?
|
Colforsin | 1 | 2014 | 74 | 0.120 |
Why?
|
Oxidation-Reduction | 2 | 2015 | 387 | 0.120 |
Why?
|
Propranolol | 1 | 2014 | 44 | 0.120 |
Why?
|
Blood Gas Analysis | 2 | 2005 | 38 | 0.120 |
Why?
|
Hot Temperature | 1 | 2015 | 208 | 0.120 |
Why?
|
Transcription, Genetic | 2 | 2011 | 1157 | 0.120 |
Why?
|
Radiography | 2 | 2006 | 809 | 0.120 |
Why?
|
Body Fluids | 2 | 2005 | 34 | 0.120 |
Why?
|
Adipose Tissue | 1 | 2016 | 259 | 0.120 |
Why?
|
Nasal Cavity | 1 | 2014 | 91 | 0.120 |
Why?
|
Up-Regulation | 2 | 2009 | 727 | 0.120 |
Why?
|
Peptide Hydrolases | 1 | 2014 | 101 | 0.120 |
Why?
|
Adenylyl Cyclases | 1 | 2014 | 100 | 0.110 |
Why?
|
Extracellular Space | 1 | 2014 | 92 | 0.110 |
Why?
|
Viral Load | 1 | 2014 | 145 | 0.110 |
Why?
|
Longevity | 1 | 2014 | 58 | 0.110 |
Why?
|
Double-Blind Method | 1 | 2018 | 1717 | 0.110 |
Why?
|
Wnt Proteins | 1 | 2014 | 130 | 0.110 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2013 | 29 | 0.110 |
Why?
|
Ferritins | 1 | 2013 | 29 | 0.110 |
Why?
|
Proteolysis | 1 | 2014 | 108 | 0.110 |
Why?
|
Cause of Death | 2 | 2018 | 269 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 112 | 0.110 |
Why?
|
Dogs | 1 | 2014 | 704 | 0.110 |
Why?
|
Enzyme Repression | 1 | 2013 | 2 | 0.110 |
Why?
|
Telomere | 1 | 2014 | 114 | 0.110 |
Why?
|
Histone Deacetylase 1 | 1 | 2013 | 15 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 207 | 0.110 |
Why?
|
Cell Nucleus | 1 | 2015 | 599 | 0.110 |
Why?
|
Myeloid Cells | 1 | 2013 | 100 | 0.110 |
Why?
|
Cell Adhesion | 2 | 2014 | 426 | 0.110 |
Why?
|
Cation Transport Proteins | 1 | 2013 | 67 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 2 | 2006 | 565 | 0.110 |
Why?
|
Risk Factors | 3 | 2013 | 5493 | 0.110 |
Why?
|
Pyroglyphidae | 1 | 2012 | 14 | 0.110 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2012 | 19 | 0.100 |
Why?
|
Transduction, Genetic | 2 | 2004 | 160 | 0.100 |
Why?
|
Microbiota | 1 | 2018 | 400 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2013 | 283 | 0.100 |
Why?
|
Immunohistochemistry | 2 | 2007 | 1799 | 0.100 |
Why?
|
Hospitalization | 1 | 2018 | 877 | 0.100 |
Why?
|
Rosuvastatin Calcium | 1 | 2012 | 29 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2013 | 153 | 0.100 |
Why?
|
Ovalbumin | 1 | 2012 | 109 | 0.100 |
Why?
|
beta-Galactosidase | 2 | 2002 | 73 | 0.100 |
Why?
|
Carcinogenesis | 1 | 2014 | 211 | 0.100 |
Why?
|
Interleukin-4 | 1 | 2012 | 130 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 170 | 0.100 |
Why?
|
Transcriptional Activation | 1 | 2013 | 292 | 0.100 |
Why?
|
Autocrine Communication | 1 | 2011 | 20 | 0.100 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2011 | 3 | 0.100 |
Why?
|
Stromal Interaction Molecule 1 | 1 | 2011 | 11 | 0.100 |
Why?
|
Staphylococcus aureus | 1 | 2015 | 276 | 0.100 |
Why?
|
Cell Adhesion Molecules | 1 | 2012 | 167 | 0.100 |
Why?
|
ORAI1 Protein | 1 | 2011 | 10 | 0.100 |
Why?
|
Central Nervous System Depressants | 1 | 2012 | 45 | 0.100 |
Why?
|
District of Columbia | 1 | 2011 | 20 | 0.100 |
Why?
|
Ozone | 1 | 2011 | 8 | 0.100 |
Why?
|
Prognosis | 2 | 2010 | 3780 | 0.100 |
Why?
|
Biomass | 1 | 2011 | 36 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 105 | 0.100 |
Why?
|
Leukocytes | 1 | 2012 | 204 | 0.100 |
Why?
|
Ligands | 1 | 2012 | 444 | 0.100 |
Why?
|
Occludin | 1 | 2011 | 66 | 0.100 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 1429 | 0.100 |
Why?
|
Caco-2 Cells | 1 | 2011 | 123 | 0.100 |
Why?
|
Tobacco Smoke Pollution | 1 | 2011 | 25 | 0.100 |
Why?
|
Zonula Occludens-1 Protein | 1 | 2011 | 70 | 0.090 |
Why?
|
Adipose Tissue, White | 1 | 2011 | 23 | 0.090 |
Why?
|
Prospective Studies | 2 | 2014 | 4284 | 0.090 |
Why?
|
Extracellular Matrix | 1 | 2012 | 244 | 0.090 |
Why?
|
Cities | 1 | 2011 | 43 | 0.090 |
Why?
|
Serotonin | 1 | 2012 | 221 | 0.090 |
Why?
|
Cyclophilins | 1 | 2010 | 8 | 0.090 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2010 | 12 | 0.090 |
Why?
|
Electric Impedance | 1 | 2011 | 110 | 0.090 |
Why?
|
Luminescent Proteins | 1 | 2011 | 144 | 0.090 |
Why?
|
Carbon Monoxide | 1 | 2011 | 93 | 0.090 |
Why?
|
Fibrin | 1 | 2011 | 86 | 0.090 |
Why?
|
bcl-2-Associated X Protein | 1 | 2010 | 46 | 0.090 |
Why?
|
Acute Disease | 2 | 2003 | 841 | 0.090 |
Why?
|
DNA | 1 | 2016 | 1307 | 0.090 |
Why?
|
Virus Replication | 1 | 2012 | 322 | 0.090 |
Why?
|
Cell Hypoxia | 1 | 2011 | 170 | 0.090 |
Why?
|
Eye Abnormalities | 1 | 2010 | 41 | 0.090 |
Why?
|
Nitrogen Dioxide | 1 | 2010 | 16 | 0.090 |
Why?
|
Pentose Phosphate Pathway | 1 | 2010 | 12 | 0.090 |
Why?
|
Colloids | 1 | 2010 | 25 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2013 | 339 | 0.090 |
Why?
|
Genes, Recessive | 1 | 2010 | 87 | 0.090 |
Why?
|
Aerobiosis | 1 | 2010 | 17 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 2 | 2009 | 290 | 0.090 |
Why?
|
Chicago | 2 | 2006 | 1427 | 0.090 |
Why?
|
Dysphonia | 1 | 2010 | 5 | 0.090 |
Why?
|
Materials Testing | 1 | 2010 | 93 | 0.090 |
Why?
|
Tight Junctions | 1 | 2011 | 150 | 0.090 |
Why?
|
RNA Interference | 1 | 2011 | 376 | 0.090 |
Why?
|
Pulmonary Gas Exchange | 1 | 2010 | 32 | 0.090 |
Why?
|
Smad Proteins | 1 | 2010 | 43 | 0.090 |
Why?
|
Tidal Volume | 1 | 2010 | 54 | 0.090 |
Why?
|
Life Expectancy | 1 | 2010 | 89 | 0.090 |
Why?
|
HCT116 Cells | 1 | 2010 | 155 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2011 | 261 | 0.090 |
Why?
|
Climate Change | 1 | 2010 | 47 | 0.090 |
Why?
|
Disease Progression | 1 | 2014 | 1488 | 0.090 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 123 | 0.090 |
Why?
|
Chest Pain | 1 | 2010 | 42 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2013 | 423 | 0.090 |
Why?
|
Crystallization | 1 | 2010 | 210 | 0.090 |
Why?
|
In Vitro Techniques | 1 | 2011 | 996 | 0.090 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 255 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 139 | 0.080 |
Why?
|
Syndrome | 1 | 2010 | 449 | 0.080 |
Why?
|
Drug Overdose | 1 | 2010 | 71 | 0.080 |
Why?
|
HEK293 Cells | 1 | 2011 | 640 | 0.080 |
Why?
|
Chromosome Aberrations | 1 | 2010 | 390 | 0.080 |
Why?
|
Estradiol | 1 | 2009 | 250 | 0.080 |
Why?
|
Biopsy | 1 | 2012 | 1183 | 0.080 |
Why?
|
Superoxide Dismutase-1 | 1 | 2008 | 48 | 0.080 |
Why?
|
Immunoblotting | 1 | 2009 | 273 | 0.080 |
Why?
|
Estrogens | 1 | 2009 | 201 | 0.080 |
Why?
|
Nanoparticles | 1 | 2010 | 164 | 0.080 |
Why?
|
Catalytic Domain | 1 | 2009 | 156 | 0.080 |
Why?
|
Cerebellum | 1 | 2010 | 249 | 0.080 |
Why?
|
Estrogen Receptor alpha | 1 | 2009 | 147 | 0.080 |
Why?
|
Severity of Illness Index | 1 | 2014 | 1838 | 0.080 |
Why?
|
Cohort Studies | 2 | 2009 | 2867 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 71 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 77 | 0.080 |
Why?
|
United States | 4 | 2021 | 6979 | 0.080 |
Why?
|
Probability | 1 | 2009 | 353 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 198 | 0.080 |
Why?
|
Clodronic Acid | 1 | 2007 | 9 | 0.080 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 316 | 0.080 |
Why?
|
Blood Coagulation Factors | 1 | 2007 | 20 | 0.070 |
Why?
|
Prothrombin Time | 1 | 2007 | 22 | 0.070 |
Why?
|
Cycloheximide | 1 | 2007 | 56 | 0.070 |
Why?
|
MicroRNAs | 1 | 2012 | 551 | 0.070 |
Why?
|
Thrombin | 1 | 2007 | 61 | 0.070 |
Why?
|
Transcription Factors | 1 | 2015 | 1653 | 0.070 |
Why?
|
Ferric Compounds | 1 | 2007 | 38 | 0.070 |
Why?
|
Hydrolysis | 1 | 2007 | 141 | 0.070 |
Why?
|
Stress, Mechanical | 1 | 2008 | 253 | 0.070 |
Why?
|
Logistic Models | 2 | 2018 | 1213 | 0.070 |
Why?
|
Chlorides | 1 | 2007 | 103 | 0.070 |
Why?
|
Cell Survival | 1 | 2009 | 983 | 0.070 |
Why?
|
Drug Combinations | 1 | 2007 | 203 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2009 | 899 | 0.070 |
Why?
|
Toluene | 1 | 2006 | 5 | 0.070 |
Why?
|
Benzothiazoles | 1 | 2006 | 16 | 0.070 |
Why?
|
Edema | 1 | 2006 | 70 | 0.070 |
Why?
|
DNA Fragmentation | 1 | 2006 | 63 | 0.070 |
Why?
|
Plasmids | 1 | 2007 | 291 | 0.070 |
Why?
|
Recurrence | 1 | 2010 | 1143 | 0.070 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 122 | 0.070 |
Why?
|
Calcium | 1 | 2011 | 1174 | 0.070 |
Why?
|
Osmotic Pressure | 1 | 2006 | 21 | 0.070 |
Why?
|
Depression | 1 | 2010 | 505 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 557 | 0.070 |
Why?
|
Electrophysiology | 1 | 2007 | 403 | 0.070 |
Why?
|
Barium Sulfate | 1 | 2006 | 43 | 0.070 |
Why?
|
Biological Transport | 1 | 2007 | 401 | 0.070 |
Why?
|
Hydrostatic Pressure | 1 | 2005 | 4 | 0.070 |
Why?
|
Physical Fitness | 1 | 2006 | 51 | 0.070 |
Why?
|
Absorption | 1 | 2005 | 25 | 0.070 |
Why?
|
Cystic Fibrosis | 1 | 2007 | 115 | 0.070 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 1045 | 0.070 |
Why?
|
Mediastinal Diseases | 1 | 2006 | 22 | 0.070 |
Why?
|
Neuroradiography | 1 | 2005 | 3 | 0.070 |
Why?
|
Treatment Outcome | 2 | 2010 | 8232 | 0.070 |
Why?
|
Medical Records | 1 | 2006 | 120 | 0.070 |
Why?
|
Low Back Pain | 1 | 2006 | 41 | 0.070 |
Why?
|
Meningitis | 1 | 2005 | 20 | 0.060 |
Why?
|
Translocation, Genetic | 1 | 2006 | 266 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 289 | 0.060 |
Why?
|
Spine | 1 | 2006 | 102 | 0.060 |
Why?
|
Cell Membrane | 2 | 2006 | 671 | 0.060 |
Why?
|
Fever | 1 | 2006 | 128 | 0.060 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2004 | 13 | 0.060 |
Why?
|
Ventilators, Mechanical | 1 | 2005 | 37 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2006 | 309 | 0.060 |
Why?
|
Urban Population | 1 | 2006 | 224 | 0.060 |
Why?
|
Radiation Pneumonitis | 1 | 2004 | 21 | 0.060 |
Why?
|
Endothelium | 1 | 2004 | 58 | 0.060 |
Why?
|
Protein Conformation | 1 | 2007 | 889 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 1150 | 0.060 |
Why?
|
Blood Circulation | 1 | 2004 | 30 | 0.060 |
Why?
|
Amiloride | 1 | 2004 | 36 | 0.060 |
Why?
|
Electromyography | 1 | 2005 | 193 | 0.060 |
Why?
|
Body Water | 1 | 2004 | 35 | 0.060 |
Why?
|
Osmolar Concentration | 1 | 2004 | 181 | 0.060 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2004 | 78 | 0.060 |
Why?
|
Brain | 1 | 2014 | 2283 | 0.060 |
Why?
|
Transfection | 1 | 2006 | 911 | 0.060 |
Why?
|
Ion Channels | 1 | 2005 | 246 | 0.060 |
Why?
|
Pulmonary Circulation | 1 | 2004 | 90 | 0.060 |
Why?
|
APACHE | 1 | 2003 | 22 | 0.060 |
Why?
|
Cardiac Output | 1 | 2004 | 156 | 0.060 |
Why?
|
Multiple Organ Failure | 1 | 2003 | 53 | 0.050 |
Why?
|
Exercise | 1 | 2006 | 323 | 0.050 |
Why?
|
Thiosulfates | 1 | 2002 | 3 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2003 | 251 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2006 | 329 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2005 | 305 | 0.050 |
Why?
|
Fluorocarbons | 1 | 2002 | 72 | 0.050 |
Why?
|
Mucociliary Clearance | 1 | 2001 | 7 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2003 | 500 | 0.050 |
Why?
|
Potassium Channels | 1 | 2004 | 343 | 0.050 |
Why?
|
Stroke Volume | 1 | 2004 | 462 | 0.050 |
Why?
|
Splanchnic Circulation | 1 | 2001 | 14 | 0.050 |
Why?
|
Brain Death | 1 | 2002 | 82 | 0.050 |
Why?
|
Incidence | 1 | 2006 | 1594 | 0.050 |
Why?
|
Cholecystitis | 1 | 2001 | 15 | 0.050 |
Why?
|
Stomach Ulcer | 1 | 2001 | 23 | 0.050 |
Why?
|
Gastrointestinal Motility | 1 | 2001 | 25 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2006 | 358 | 0.050 |
Why?
|
Esophagitis | 1 | 2001 | 43 | 0.050 |
Why?
|
ROC Curve | 1 | 2003 | 781 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2006 | 787 | 0.050 |
Why?
|
Specimen Handling | 1 | 2001 | 102 | 0.050 |
Why?
|
Respiratory Muscles | 1 | 2000 | 13 | 0.050 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2000 | 27 | 0.050 |
Why?
|
Forecasting | 1 | 2001 | 306 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 2062 | 0.040 |
Why?
|
Diarrhea | 1 | 2001 | 182 | 0.040 |
Why?
|
Blood Pressure | 1 | 2004 | 900 | 0.040 |
Why?
|
Comorbidity | 1 | 2003 | 949 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2000 | 190 | 0.040 |
Why?
|
Hemodynamics | 1 | 2003 | 730 | 0.040 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2019 | 16 | 0.040 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 17 | 0.040 |
Why?
|
Genotype | 1 | 2004 | 1848 | 0.040 |
Why?
|
Forkhead Box Protein O3 | 1 | 2018 | 21 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2000 | 162 | 0.040 |
Why?
|
STAT Transcription Factors | 1 | 2018 | 18 | 0.040 |
Why?
|
Janus Kinases | 1 | 2018 | 23 | 0.040 |
Why?
|
Coronary Disease | 1 | 2000 | 260 | 0.040 |
Why?
|
Intubation, Intratracheal | 1 | 2000 | 148 | 0.040 |
Why?
|
National Institute of Environmental Health Sciences (U.S.) | 1 | 2018 | 3 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2006 | 1176 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 3445 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2004 | 890 | 0.040 |
Why?
|
Propensity Score | 1 | 2018 | 147 | 0.040 |
Why?
|
Heart Diseases | 1 | 2000 | 298 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2000 | 319 | 0.040 |
Why?
|
Smoking | 1 | 2001 | 621 | 0.040 |
Why?
|
Mutation | 1 | 2009 | 4142 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2010 | 2358 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2019 | 388 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2009 | 3007 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2018 | 988 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 2413 | 0.030 |
Why?
|
Rho Guanine Nucleotide Exchange Factors | 1 | 2014 | 16 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 56 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2015 | 73 | 0.030 |
Why?
|
Genome | 1 | 2018 | 386 | 0.030 |
Why?
|
Protective Agents | 1 | 2014 | 33 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 125 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2019 | 1858 | 0.030 |
Why?
|
Cytosol | 1 | 2012 | 193 | 0.030 |
Why?
|
DNA Primers | 1 | 2012 | 543 | 0.020 |
Why?
|
Trefoil Factor-1 | 1 | 2009 | 2 | 0.020 |
Why?
|
Adolescent | 1 | 2003 | 9256 | 0.020 |
Why?
|
Base Sequence | 1 | 2012 | 2327 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2009 | 393 | 0.020 |
Why?
|
Hyperthermia, Induced | 1 | 2005 | 73 | 0.010 |
Why?
|
Hypothermia, Induced | 1 | 2005 | 82 | 0.010 |
Why?
|
Procaterol | 1 | 2001 | 1 | 0.010 |
Why?
|
Epithelial Sodium Channels | 1 | 2001 | 7 | 0.010 |
Why?
|
Gene Transfer, Horizontal | 1 | 2001 | 39 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2001 | 392 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2001 | 681 | 0.010 |
Why?
|